Skip to content
Recall Observatory FDA recall evidence

Device product

Creatinine Plus. Intended for use on Hitachi/MODULAR systems for the quantitative determination of the creatinine concentration in serum, plasma, and urine.

Z-1922-2015

May 07, 2015

Class II

Product summary

Firm
Roche Diagnostics Operations, Inc.
Event
Event 71182
Status
Terminated
Classification
Class II
Quantity
6,255 analytical units distributed
Official record key
device-enforcement:Z-1922-2015

Official wording

Reason: Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.

Code information: Catalog Numbers: 11775685216; 11875566216; 11875582216.

Distribution pattern: US (nationwide) including PR.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Possible drug interference when using the Trinder reaction method on multiple Cobas Analyzers. Results of Trinder tests may be falsely decreased when the tests are run with urine samples (Creatinine plus and Uric Acid applications only) or blood samples collected before sufficient time has lapsed after the administration of the drugs Acetaminophen and N-acetylcysteine.